Angiotensin II infusion-induced inflammation, monocytic fibroblast precursor infiltration, and cardiac fibrosis are pressure dependent

Cardiovascular Toxicology

Volumn 11, Issue 2, 2011, Pages 157-167

  Qi, Guanming ^a   Jia, Lixin ^b   Li, Yulin ^a   Bian, Yunfei ^b   Cheng, Jizhong ^a   Li, Huihua ^a   Xiao, Chuanshi ^b   Du, Jie ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b SHANXI MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin II; Cardiac remodeling; Hydralazine; Hypertension; Inflammation

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; CD45 ANTIGEN; HYDRALAZINE; RENIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE MEASUREMENT; C57BL 6 MOUSE; CELL INFILTRATION; CONTROLLED STUDY; HEART LEFT VENTRICLE MASS; HEART MUSCLE FIBROSIS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATORY INFILTRATE; MALE; MOUSE; NONHUMAN; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANGIOTENSIN II; ANIMALS; ANTIGENS, CD45; BLOOD PRESSURE; FIBROSIS; HYDRALAZINE; HYPERTROPHY, LEFT VENTRICULAR; INFLAMMATION; INFLAMMATION MEDIATORS; INFUSION PUMPS; MALE; MICE; MICE, INBRED C57BL; MONOCYTES; MYOFIBROBLASTS; RANDOM ALLOCATION;

MUS;

EID: 79958032667     PISSN: 15307905     EISSN: 15590259     Source Type: Journal    
DOI: 10.1007/s12012-011-9109-z     Document Type: Article

References (51)

1. P Brassard F Amiri EL Schiffrin 2005 Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries Hypertension 46 3 598 606 16043661 10.1161/01.HYP. 0000176744.15592.7d (Pubitemid 41376842)
2. S Katragadda RR Arora 2010 Role of angiotensin-converting enzyme inhibitors in vascular modulation: Beyond the hypertensive effects American Journal of Therapeutics 17 1 e11 e23 20090429 10.1097/MJT.0b013e31815addd9
3. DL Mann 2002 Angiotensin II as an inflammatory mediator: Evolving concepts in the role of the renin angiotensin system in the failing heart Cardiovascular Drugs and Therapy 16 1 7 9 12085982 10.1023/A:1015355112501 (Pubitemid 34606606)
4. K Sekiguchi X Li M Coker M Flesch PM Barger N Sivasubramanian, et al. 2004 Cross-regulation between the renin-angiotensin system and inflammatory mediators in cardiac hypertrophy and failure Cardiovascular Research 63 3 433 442 15276468 10.1016/j.cardiores.2004.02.005 (Pubitemid 38970187)
5. TA Wynn 2007 Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases Journal of Clinical Investigation 117 3 524 529 17332879 10.1172/JCI31487 (Pubitemid 46348506)
6. TA Wynn 2008 Cellular and molecular mechanisms of fibrosis Journal of Pathology 214 199 210 18161745 10.1002/path.2277 (Pubitemid 351160157)
7. P Camelliti TK Borg P Kohl 2005 Structural and functional characterisation of cardiac fibroblasts Cardiovascular Research 65 1 40 51 15621032 10.1016/j.cardiores.2004.08.020 (Pubitemid 40038477)
8. G Gabbiani 2003 The myofibroblast in wound healing and fibrocontractive diseases Journal of Pathology 200 4 500 503 12845617 10.1002/path.1427 (Pubitemid 36818250)
9. SB Haudek J Cheng J Du Y Wang J Hermosillo-Rodriguez J Trial, et al. 2010 Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy Journal of Molecular and Cellular Cardiology 49 3 499 507 20488188 10.1016/j.yjmcc.2010.05.005
10. SB Haudek Y Xia P Huebener JM Lee S Carlson JR Crawford, et al. 2006 Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice Proceedings of the National Academy of Sciences USA 103 48 18284 18289 10.1073/pnas.0608799103 (Pubitemid 44871650)
11. C Marchesi P Paradis EL Schiffrin 2008 Role of the renin-angiotensin system in vascular inflammation Trends in Pharmacological Sciences 29 7 367 374 18579222 10.1016/j.tips.2008.05.003
12. L Piqueras P Kubes A Alvarez E O'Connor AC Issekutz JV Esplugues, et al. 2000 Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation Circulation 102 17 2118 2123 11044430
13. TD Liao XP Yang YH Liu EG Shesely MA Cavasin WA Kuziel, et al. 2008 Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension Hypertension 52 256 263 18541733 10.1161/HYPERTENSIONAHA.108.112706
14. E Braunwald MJ Domanski SE Fowler NL Geller BJ Gersh J Hsia, et al. 2004 Angiotensin-converting-enzyme inhibition in stable coronary artery disease New England Journal of Medicine 351 20 2058 2068 15531767 10.1056/NEJMoa042739 (Pubitemid 39482499)
15. MC Zimmerman E Lazartigues RV Sharma RL Davisson 2004 Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system Circulation Research 95 210 216 15192025 10.1161/01.RES.0000135483.12297.e4 (Pubitemid 38988688)
16. JF Paton H Waki AP Abdala J Dickinson S Kasparov 2007 Vascular-brain signaling in hypertension: Role of angiotensin II and nitric oxide Current Hypertension Reports 9 3 242 247 17519132 10.1007/s11906-007-0043-1 (Pubitemid 46894818)
17. M Cousin MA Custaud C Baron-Menguy B Toutain O Dumont AL Guihot, et al. 2010 Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries Hypertension 55 1 109 115 19948989 10.1161/HYPERTENSIONAHA.108.127456
18. J Chen PJ Kuhlencordt J Astern R Gyurko PL Huang 2001 Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice Circulation 104 20 2391 2394 11705813 10.1161/hc4501.099729 (Pubitemid 33108369)
19. PJ Marvar SR Thabet TJ Guzik HE Lob LA McCann C Weyand, et al. 2010 Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension Circulation Research 107 263 270 20558826 10.1161/CIRCRESAHA.110.217299
20. H Vidrio M Medina P Gonzalez-Romo M Lorenzana-Jimenez P Diaz-Arista A Baeza 2003 Semicarbazide-sensitive amine oxidase substrates potentiate hydralazine hypotension: Possible role of hydrogen peroxide Journal of Pharmacology and Experimental Therapeutics 307 497 504 12970383 10.1124/jpet.103.055350 (Pubitemid 37310662)
21. J Wang N Xu X Feng N Hou J Zhang X Cheng, et al. 2005 Targeted disruption of Smad4 in cardiomyocytes results in cardiac hypertrophy and heart failure Circulation Research 97 8 821 828 16151019 10.1161/01.RES.0000185833.42544.06 (Pubitemid 41447133)
22. DK Singla GE Lyons TJ Kamp 2007 Transplanted embryonic stem cells following mouse myocardial infarction inhibit apoptosis and cardiac remodeling American Journal of Physiology Heart Circulatory Physiology 293 H1308 H1314 10.1152/ajpheart.01277.2006 (Pubitemid 47254236)
23. J Cheng J Du 2007 Mechanical stretch simulates proliferation of venous smooth muscle cells through activation of the insulin-like growth factor-1 receptor Arteriosclerosis, Thrombosis, and Vascular Biology 27 8 1744 1751 17541019 10.1161/ATVBAHA.107.147371 (Pubitemid 47207169)
24. X Wu J Cheng P Li M Yang S Qiu P Liu, et al. 2010 Mechano-sensitive transcriptional factor Egr-1 regulates insulin-like growth factor-1 receptor expression and contributes to neointima formation in vein grafts Arteriosclerosis, Thrombosis, and Vascular Biology 30 3 471 476 19965784 10.1161/ATVBAHA.109.184259
25. Y Ma L Zhang T Peng J Cheng S Taneja J Zhang, et al. 2006 Angiotensin II stimulates transcription of insulin-like growth factor I receptor in vascular smooth muscle cells: Role of nuclear factor-kappaB Endocrinology 147 3 1256 1263 16322063 10.1210/en.2005-0888 (Pubitemid 43244358)
26. W Wang XR Huang AG Li F Liu JH Li LD Truong, et al. 2005 Signaling mechanism of TGF-beta1 in prevention of renal inflammation: Role of Smad7 Journal of the American Society of Nephrology 16 5 1371 1383 15788474 10.1681/ASN.2004121070 (Pubitemid 41716521)
27. L Zhang J Cheng Y Ma W Thomas J Zhang J Du 2005 Dual pathways for nuclear factor kappaB activation by angiotensin II in vascular smooth muscle: Phosphorylation of p65 by IkappaB kinase and ribosomal kinase Circulation Research 97 10 975 982 16224066 10.1161/01.RES.0000190589.52286.41 (Pubitemid 41668910)
28. H Kobori A Ichihara H Suzuki T Takenaka Y Miyashita M Hayashi, et al. 1997 Role of the renin-angiotensin system in cardiac hypertrophy induced in rats by hyperthyroidism American Journal of Physiology 273 2 Pt 2 H593 H599 9277473
29. J Xu OA Carretero CX Lin MA Cavasin EG Shesely JJ Yang, et al. 2007 Role of cardiac overexpression of ANG II in the regulation of cardiac function and remodeling postmyocardial infarction American Journal of Physiology Heart Circulatory Physiology 293 3 H1900 H1907 10.1152/ajpheart.00379.2007 (Pubitemid 47367241)
30. Y Xia K Lee N Li D Corbett L Mendoza NG Frangogiannis 2009 Characterization of the inflammatory and fibrotic response in a mouse model of cardiac pressure overload Histochemistry and Cell Biology 131 4 471 481 19030868 10.1007/s00418-008-0541-5
31. GY Lip 2000 Target organ damage and the prothrombotic state in hypertension Hypertension 36 6 975 977 11116110
32. AJ Polichnowski AW Cowley 2009 Pressure-induced renal injury in angiotensin II versus norepinephrine-induced hypertensive rats Hypertension 54 1269 1277 19858406 10.1161/HYPERTENSIONAHA.109.139287
33. TM Paravicini RM Touyz 2006 Redox signaling in hypertension Cardiovascular Research 71 247 258 16765337 10.1016/j.cardiores.2006.05.001
34. P Zahradka JP Werner S Buhay B Litchie G Helwer S Thomas 2002 NF-kappaB activation is essential for angiotensin II-dependent proliferation and migration of vascular smooth muscle cells Journal of Molecular and Cellular Cardiology 34 12 1609 1621 12505059 10.1006/jmcc.2002.2111 (Pubitemid 35454476)
35. EL Schiffrin 2005 Vascular endothelin in hypertension Vascular Pharmacology 43 1 19 29 15955745 10.1016/j.vph.2005.03.004 (Pubitemid 40828829)
36. AH Danser 2010 Cardiac angiotensin II: Does it have a function? American Journal of Physiology Heart Circulatory Physiology 299 5 H1304 H1306 10.1152/ajpheart.00881.2010
37. DN Muller EM Mervaala F Schmidt JK Park R Dechend E Genersch, et al. 2000 Effect of bosentan on NF-kappaB, inflammation, and tissue factor in angiotensin II-induced end-organ damage Hypertension 36 282 290 10948091 (Pubitemid 30627001)
38. GY Chen G Nunez 2010 Sterile inflammation: Sensing and reacting to damage Nature Reviews Immunology 10 826 837 21088683 10.1038/nri2873
39. AR Brasier A Recinos III MS Eledrisi 2002 Vascular inflammation and the renin-angiotensin system Arteriosclerosis, Thrombosis, and Vascular Biology 22 8 1257 1266 12171785 10.1161/01.ATV.0000021412.56621.A2 (Pubitemid 34875734)
40. B Jiang S Xu X Hou DR Pimentel RA Cohen 2004 Angiotensin II differentially regulates interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell adhesion molecule-1 (VCAM-1) expression: Role of p38 MAPK Journal of Biological Chemistry 279 19 20363 20368 15001568 10.1074/jbc.M314172200 (Pubitemid 38623482)
41. H Kai F Kuwahara K Tokuda T Imaizumi 2005 Diastolic dysfunction in hypertensive hearts: Roles of perivascular inflammation and reactive myocardial fibrosis Hypertension Research 28 6 483 490 16231753 10.1291/hypres.28.483 (Pubitemid 41195386)
42. G Gabbiani 1998 Evolution and clinical implications of the myofibroblast concept Cardiovascular Research 38 3 545 548 9747425 10.1016/S0008-6363(98) 00065-0 (Pubitemid 28319866)
43. KE Porter NA Turner DJ O'Regan SG Ball 2004 Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: Inhibition by simvastatin Cardiovascular Research 64 3 507 515 15537504 10.1016/j.cardiores.2004.07.020 (Pubitemid 39505429)
44. VV Petrov RH Fagard PJ Lijnen 2002 Stimulation of collagen production by transforming growth factor-beta1 during differentiation of cardiac fibroblasts to myofibroblasts Hypertension 39 258 263 11847194 10.1161/hy0202.103268 (Pubitemid 34165225)
45. DA Siwik DL Chang WS Colucci 2000 Interleukin-1beta and tumor necrosis factor-alpha decrease collagen synthesis and increase matrix metalloproteinase activity in cardiac fibroblasts in vitro Circulation Research 86 12 1259 1265 10864917 (Pubitemid 30436667)
46. B Klanke N Cordasic A Hartner RE Schmieder R Veelken KF Hilgers 2008 Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension Nephrology, Dialysis, Transplantation 23 11 3456 3463 18515791 10.1093/ndt/gfn301
47. D Watanabe A Tanabe M Naruse S Morikawa T Ezaki K Takano 2009 Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders Hypertension Research 32 9 807 815 19662019 10.1038/hr.2009.106
48. FN Mario A Farhad V Agostino ND Quy LS Ernesto 2005 Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy Canadian Journal of Physiology and Pharmacology 83 999 1006 10.1139/y05-068 (Pubitemid 43385544)
49. C Maud C Marc-Antoine BM Céline T Bertrand D Odile G Anne-Laure, et al. 2010 Role of angiotensin II in the remodeling induced by a chronic increase in flow in rat mesenteric resistance arteries Hypertension 55 109 115 10.1161/HYPERTENSIONAHA.108.127456
50. CM Ferrario MC Chappell EA Tallant KB Brosnihan DI Diz 1997 Counter regulatory actions of angiotensin-(1-7) Hypertension 30 535 541 9322978
51. AJ Rickard J Morgan G Tesch JW Funder PJ Fuller MJ Young 2009 Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure Hypertension 54 3 537 543 19635989 10.1161/HYPERTENSIONAHA.109.131110